Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Shalini Dogra"'
Publikováno v:
Neurobiology of Disease, Vol 118, Iss , Pp 94-107 (2018)
GPR40 (Free fatty acid receptor 1) has emerged as an important therapeutic target for diabetes. Several studies have demonstrated the association of comorbid psychiatric conditions with decreased n-3 polyunsaturated fatty acids, which may act as an a
Externí odkaz:
https://doaj.org/article/9a2ebfb655ce44b1ab8a26dcad9eb9fb
Autor:
Shalini Dogra, P. Jeffrey Conn
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Central Nervous System Pharmacology - Neuropharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::830e7d04b23906f41001728fe98841e5
https://doi.org/10.1124/jpet.122.195740
https://doi.org/10.1124/jpet.122.195740
Autor:
Jerri Rook, Zixiu Xiang, Jonathan Dickerson, Shalini Dogra, Kendall Jensen, Insung Kim, Megan Ohler, Kelly Weiss, P. Jeffrey Conn
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Central Nervous System Pharmacology - Behavioral.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c500f4aeea526375bc0949b7c50816d
https://doi.org/10.1124/jpet.122.253010
https://doi.org/10.1124/jpet.122.253010
Autor:
Ferdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, Rosamaria Orlando, Anna Rita Zuena, P. Jeffrey Conn, Shalini Dogra, Max E. Joffe
Publikováno v:
Neuropharmacology. 235:109569
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d59a0f1858bd926c9b8850fc76a1a59c
https://doi.org/10.1016/j.neuropharm.2023.109569
https://doi.org/10.1016/j.neuropharm.2023.109569
Autor:
Rocco G. Gogliotti, Weilun Qian, Ferdinando Nicoletti, Max E. Joffe, P. Jeffrey Conn, Shalini Dogra, Colleen M. Niswender, Branden J. Stansley, Craig W. Lindsley, Zixiu Xiang
Publikováno v:
Biological Psychiatry. 90:385-398
Background Polymorphisms in GRM3, the gene encoding the mGlu3 metabotropic glutamate receptor, are associated with impaired cognition and neuropsychiatric disorders such as schizophrenia. Limited availability of selective genetic and molecular tools
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4cdb56df69d8bf35d7d940f7842fb7c
https://doi.org/10.1016/j.biopsych.2021.02.970
https://doi.org/10.1016/j.biopsych.2021.02.970
Autor:
Xin, Lin, Nicole M, Fisher, Shalini, Dogra, Rebecca K, Senter, Carson W, Reed, Jacob J, Kalbfleisch, Craig W, Lindsley, Wesley B, Asher, Zixiu, Xiang, Colleen M, Niswender, Jonathan A, Javitch
Publikováno v:
The Journal of biological chemistry. 298(10)
Glutamate acts at eight metabotropic glutamate (mGlu) receptor subtypes expressed in a partially overlapping fashion in distinct brain circuits. Recent evidence indicates that specific mGlu receptor protomers can heterodimerize and that these heterod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7f4c42c661608b83bf6eebb0aa05b58
https://pubmed.ncbi.nlm.nih.gov/36063995
https://pubmed.ncbi.nlm.nih.gov/36063995
Autor:
Colleen M. Niswender, P. Jeffrey Conn, Nicole M. Fisher, Sheryl Anne D. Vermudez, Chiaki I. Santiago, Shalini Dogra, Max E. Joffe
Publikováno v:
Neuropsychopharmacology. 46:2148-2157
Clinical and translational studies suggest that prefrontal cortex (PFC) dysregulation is a hallmark feature of several affective disorders. Thus, investigating the mechanisms involved in the regulation of PFC function and synaptic plasticity could ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::157d9e8c570f44fcf2ef40c30f596796
https://doi.org/10.1038/s41386-021-01041-2
https://doi.org/10.1038/s41386-021-01041-2
Autor:
Shalini Dogra, P. Jeffrey Conn
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01e262cf70a69323e1ace501d9c632a8
https://doi.org/10.1096/fasebj.2022.36.s1.r6041
https://doi.org/10.1096/fasebj.2022.36.s1.r6041
Autor:
Shalini Dogra, P. Jeffrey Conn
Publikováno v:
Mol Pharmacol
Accumulating evidence of glutamatergic abnormalities in the brains of schizophrenia patients has led to efforts to target various components of glutamatergic signaling as potential new approaches for schizophrenia. Exciting research suggests that met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34039a5a67ca0509a779e834c41f6f4b
https://europepmc.org/articles/PMC9092465/
https://europepmc.org/articles/PMC9092465/
Publikováno v:
Pharmacology Biochemistry and Behavior. 221:173493
Glutamate is a major excitatory neurotransmitter in the central nervous system (CNS) and abnormalities in the glutamatergic system underlie various CNS disorders. As metabotropic glutamate receptor 3 (mGlu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ccd04d3acbb55cfa97cfd7ad9c6a25
https://doi.org/10.1016/j.pbb.2022.173493
https://doi.org/10.1016/j.pbb.2022.173493